the future??, page-7

And I would ask what has happened with the delay in skin trials. After all this time we have 12 out of 20 participants? This was forecast to move very quickly. Why? Have they over estimated potential candidates? Is there recruitment method flawed? How could they get this so wrong? Did they read the stats wrong? It's hard to see how this wasn't simply a very poor reading of how this would pan out = poor management and more costs churned in the meantime. Am I wrong about this?